Adaptimmune Therapeutics (ADAP)
0.27
0.01 (3.77%)
At close: Apr 24, 2025, 3:59 PM
0.28
4.09%
After-hours: Apr 24, 2025, 07:33 PM EDT
Adaptimmune Therapeutics Revenue
Adaptimmune Therapeutics reported an annual revenue of $178.03M, reflecting a 195.34% growth. For the quarter ending December 31, 2024, Adaptimmune Therapeutics generated $3.22M in revenue.
Revenue (ttm)
$178.03M
Revenue Growth
195.34%
Price / Sales Ratio
0.76
Revenue / Employee
$351.84K
Employees
506
Market Cap
68.82M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|---|---|
| Dec 31, 2024 | 178.03M | +195.34% |
| Dec 31, 2023 | 60.28M | +122.05% |
| Dec 31, 2022 | 27.15M | +341.50% |
| Dec 31, 2021 | 6.15M | +55.36% |
| Dec 31, 2020 | 3.96M | n/a |